Man Group
RDY icon

Man Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Man Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.39M Buy
371,768
+298,016
+404% +$4.02M 0.01% 1098
2026
Q1 		$1.02M Sell
73,752
-151,847
-67% -$2.11M ﹤0.01% 1828
2025
Q4 		$3.17M Buy
+225,599
New +$3.16M 0.01% 1269
2025
Q3 		– Sell
-43,334
Closed -$651K – 2424
2025
Q2 		$651K Sell
43,334
-31,206
-42% -$446K ﹤0.01% 1746
2025
Q1 		$983K Sell
74,540
-82,426
-53% -$1.14M ﹤0.01% 1586
2024
Q4 		$2.48M Sell
156,966
-885,729
-85% -$13.3M 0.01% 1252
2024
Q3 		$16.6M Buy
1,042,695
+439,820
+73% +$7.08M 0.04% 517
2024
Q2 		$9.19M Sell
602,875
-2,924,940
-83% -$41.9M 0.02% 738
2024
Q1 		$51.8M Sell
3,527,815
-298,150
-8% -$4.35M 0.13% 163
2023
Q4 		$53.2M Buy
+3,825,965
New +$51.2M 0.15% 157
2023
Q3 		– Sell
-777,430
Closed -$10.5M – 154
2023
Q2 		$9.81M Buy
+777,430
New +$9.08M 0.03% 629
2023
Q1 		– Sell
-173,665
Closed -$1.87M – 1155
2022
Q4 		$1.8M Sell
173,665
-31,380
-15% -$339K 0.01% 1144
2022
Q3 		$2.15M Buy
+205,045
New +$2.18M 0.01% 1044
2022
Q2 		– Sell
-231,045
Closed -$2.51M – 1084
2022
Q1 		$2.58M Buy
231,045
+39,500
+21% +$448K 0.01% 1141
2021
Q4 		$2.51M Sell
191,545
-11,500
-6% -$145K 0.01% 1111
2021
Q3 		$2.65M Sell
203,045
-1,500
-0.7% -$20K 0.01% 1089
2021
Q2 		$3.01M Sell
204,545
-33,955
-14% -$475K 0.01% 1095
2021
Q1 		$2.93M Buy
238,500
+11,000
+5% +$141K 0.01% 956
2020
Q4 		$3.24M Sell
227,500
-233,000
-51% -$3.14M 0.01% 1009
2020
Q3 		$6.41M Sell
460,500
-271,880
-37% -$3.24M 0.03% 689
2020
Q2 		$7.76M Buy
732,380
+261,500
+56% +$2.66M 0.04% 462
2020
Q1 		$3.8M Buy
+470,880
New +$3.93M 0.02% 612
2019
Q1 		– Sell
-480,500
Closed -$3.62M – 2049
2018
Q4 		$3.62M Buy
+480,500
New +$3.38M 0.02% 934

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Man Group's RDY Position: Q2 2026 in Review

Man Group increased its Dr. Reddy's Laboratories (RDY) stake by 404% in Q2 2026, buying an estimated $4.02M and bringing the position to 371,768 shares worth $5.39M. The position accounts for 0.01% of the portfolio, ranked #1098.

Man Group first reported a position in RDY in Q4 2018 and has held it in 23 quarters since. The position peaked at $53.2M in Q4 2023. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Man Group held 371,768 shares of Dr. Reddy's Laboratories worth $5.39M as of Q2 2026.
  • Man Group bought 298,016 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $4.02M.
  • Dr. Reddy's Laboratories made up 0.01% of Man Group's portfolio in Q2 2026, its #1098 holding.
  • Man Group first reported a position in Dr. Reddy's Laboratories in Q4 2018 and has held it in 23 quarters since.
  • Man Group's Dr. Reddy's Laboratories position peaked at $53.2M in Q4 2023.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.